Expertise in
26
conditions

Dr. Ross E. Krasnow

Urology
MedStar Georgetown Cancer Institute At MedStar Washington Hospital Center
110 Irving St NW, 
Washington, DC 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
17 Years of Experience
Expertise in
26
conditions
MedStar Georgetown Cancer Institute At MedStar Washington Hospital Center
110 Irving St NW, 
Washington, DC 

Overview

Ross Krasnow is a Urologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 17 years.

Dr. Krasnow is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy.

He is actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 3 clinical trials. Dr. Krasnow is currently accepting new patients.

Graduate Year

2009

Specialties

Urology

Licenses

Urology in MD

Hospital Affiliations

Medstar Georgetown University Hospital
Medstar Washington Hospital Center
Medstar Saint Mary's Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center
110 Irving St NW, Washington, DC 20010

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Enrollment Status: Recruiting
Publish Date: September 11, 2025
Intervention Type: Procedure, Drug, Other, Radiation
Study Drugs: Abiraterone, Bicalutamide, Degarelix, Docetaxel, Flutamide, Goserelin acetate, Histrelin acetate, Leuprolide acetate, Nilutamide, Prednisone, Triptorelin
Study Phase: Phase 3
A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers
A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers
Enrollment Status: Active_not_recruiting
Publish Date: September 04, 2026
Intervention Type: Other, Drug
Study Drug: Sinecatechins
Study Phase: Phase 2
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Biological, Procedure
Study Drug: Nivolumab
Study Phase: Phase 3
View 2 Less Clinical Trial

31 Total Publications

Functional and oncologic outcomes of prostate capsule-sparing radical cystectomy: A systematic review and meta-analysis.
Functional and oncologic outcomes of prostate capsule-sparing radical cystectomy: A systematic review and meta-analysis.
Journal: Urologic oncology
Published: July 02, 2023
Similar Doctors
Expertise in
6
conditions
Dr. Mark W. Ball
Urology | Plastic Surgery
Expertise in
6
conditions
Dr. Mark W. Ball
Urology | Plastic Surgery
Referral may be required
Before you request
10 Center Drive Rm 2-5942, 
Bethesda, MD 
 (5.8 miles away)
240-858-3700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Ball is a Urologist and a Plastic Surgeon practicing medicine in Bethesda, Maryland. Dr. Ball is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Von Hippel-Lindau (VHL) Syndrome, Renal Cell Carcinoma (RCC), Renal Oncocytoma, Nephrectomy, and Prostatectomy. Dr. Ball is board certified in American Board Of Urology. Dr. Ball is currently accepting new patients.

Expertise in
35
conditions
Expertise in
35
conditions
Referral may be required

Chesapeake Urology Associates (Hanover)

7580 Buckingham Blvd, Ste 110, 
Hanover, MD 
 (23.1 miles away)
410-760-9400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rian Dickstein is a Urologist practicing medicine in Hanover, Maryland. Dr. Dickstein is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Hydronephrosis, Ureteroscopy, and Nephrectomy. Dr. Dickstein is board certified in American Board Of Urology - Urology, 2014 and The American Board Of Urology - Urology. Dr. Dickstein is currently accepting new patients.

Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required
Before you request

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10803 Falls Road, Pavilion III STE 3300, 
Lutherville, MD 
 (40.5 miles away)
410-955-6100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Arthur Burnett is a Urologist practicing medicine in Lutherville, Maryland. Dr. Burnett is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Priapism, Erectile Dysfunction (ED), Peyronie Disease, Prostatectomy, and Penectomy. Dr. Burnett is board certified in American Board Of Urology. Dr. Burnett is currently accepting new patients.

Frequently Asked Questions about Dr. Ross E. Krasnow

How do I make an appointment with Dr. Ross E. Krasnow?

You can book an appointment with Dr. Ross E. Krasnow by calling their office at 202-877-6998. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ross E. Krasnow a top-rated expert for Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ross E. Krasnow is classified as an Distinguished expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ross E. Krasnow specialize in?

While Dr. Ross E. Krasnow is a Urology, they have specific expertise in Bladder Cancer, Muscle Invasive Bladder Cancer, and Renal Cell Carcinoma (RCC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Ross E. Krasnow participate in research or clinical trials?

Yes. Dr. Ross E. Krasnow has published 31 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Ross E. Krasnow's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ross E. Krasnow accept my insurance?

Dr. Ross E. Krasnow accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 202-877-6998 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Krasnow's expertise for a condition
ConditionClose
    View All 14 Distinguished Conditions
    View All 12 Advanced Conditions
    View All 31 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile